Global Hormonal Contraception Market Research Report 2021

1 Hormonal Contraception Market Overview

• 1.1 Product Overview and Scope of Hormonal Contraception
• 1.2 Hormonal Contraception Segment by Hormone
  • 1.2.1 Global Hormonal Contraception Sales Growth Rate Comparison by Hormone (2021-2027)
  • 1.2.2 Androgens
  • 1.2.3 Estrogens
  • 1.2.4 Progestrogens
  • 1.2.5 Antiandrogens
  • 1.2.6 Gonadotropins
• 1.3 Hormonal Contraception Segment by Application
  • 1.3.1 Hormonal Contraception Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinics
  • 1.3.4 Gynaecology Centers
  • 1.3.5 Others
• 1.4 Global Hormonal Contraception Market Size Estimates and Forecasts
  • 1.4.1 Global Hormonal Contraception Revenue 2016-2027
  • 1.4.2 Global Hormonal Contraception Sales 2016-2027
  • 1.4.3 Hormonal Contraception Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hormonal Contraception Market Competition by Manufacturers

• 2.1 Global Hormonal Contraception Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Hormonal Contraception Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Hormonal Contraception Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Hormonal Contraception Manufacturing Sites, Area Served, Product Type
• 2.5 Hormonal Contraception Market Competitive Situation and Trends
  • 2.5.1 Hormonal Contraception Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Hormonal Contraception Players Market Share by Revenue
  • 2.5.3 Global Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hormonal Contraception Retrospective Market Scenario by Region

• 3.1 Global Hormonal Contraception Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Hormonal Contraception Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Hormonal Contraception Market Facts & Figures by Country
  • 3.3.1 North America Hormonal Contraception Sales by Country
  • 3.3.2 North America Hormonal Contraception Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Hormonal Contraception Market Facts & Figures by Country
  • 3.4.1 Europe Hormonal Contraception Sales by Country
  • 3.4.2 Europe Hormonal Contraception Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Hormonal Contraception Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Hormonal Contraception Sales by Region
  • 3.5.2 Asia Pacific Hormonal Contraception Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Hormonal Contraception Market Facts & Figures by Country
  • 3.6.1 Latin America Hormonal Contraception Sales by Country
  • 3.6.2 Latin America Hormonal Contraception Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Hormonal Contraception Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Hormonal Contraception Sales by Country
  • 3.7.2 Middle East and Africa Hormonal Contraception Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Hormonal Contraception Historic Market Analysis by Type

• 4.1 Global Hormonal Contraception Sales Market Share by Type (2016-2021)
• 4.2 Global Hormonal Contraception Revenue Market Share by Type (2016-2021)
• 4.3 Global Hormonal Contraception Price by Type (2016-2021)

5 Global Hormonal Contraception Historic Market Analysis by Application

• 5.1 Global Hormonal Contraception Sales Market Share by Application (2016-2021)
• 5.2 Global Hormonal Contraception Revenue Market Share by Application (2016-2021)
• 5.3 Global Hormonal Contraception Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Bayer AG
  • 6.1.1 Bayer AG Corporation Information
  • 6.1.2 Bayer AG Description and Business Overview
  • 6.1.3 Bayer AG Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Bayer AG Product Portfolio
  • 6.1.5 Bayer AG Recent Developments/Updates
• 6.2 Merck & Co., Inc.
  • 6.2.1 Merck & Co., Inc. Corporation Information
  • 6.2.2 Merck & Co., Inc. Description and Business Overview
  • 6.2.3 Merck & Co., Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Merck & Co., Inc. Product Portfolio
  • 6.2.5 Merck & Co., Inc. Recent Developments/Updates
• 6.3 Pfizer, Inc.
  • 6.3.1 Pfizer, Inc. Corporation Information
  • 6.3.2 Pfizer, Inc. Description and Business Overview
  • 6.3.3 Pfizer, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Pfizer, Inc. Product Portfolio
  • 6.3.5 Pfizer, Inc. Recent Developments/Updates
• 6.4 Agile Therapeutics, Inc.
  • 6.4.1 Agile Therapeutics, Inc. Corporation Information
  • 6.4.2 Agile Therapeutics, Inc. Description and Business Overview
  • 6.4.3 Agile Therapeutics, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Agile Therapeutics, Inc. Product Portfolio
  • 6.4.5 Agile Therapeutics, Inc. Recent Developments/Updates
• 6.5 Teva Pharmaceutical Industries Ltd.
  • 6.5.1 Teva Pharmaceutical Industries Ltd. Corporation Information
  • 6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
  • 6.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Teva Pharmaceutical Industries Ltd. Product Portfolio
  • 6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
• 6.6 Amgen
  • 6.6.1 Amgen Corporation Information
  • 6.6.2 Amgen Description and Business Overview
  • 6.6.3 Amgen Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Amgen Product Portfolio
  • 6.6.5 Amgen Recent Developments/Updates
• 6.7 Cipla Ltd.
  • 6.6.1 Cipla Ltd. Corporation Information
  • 6.6.2 Cipla Ltd. Description and Business Overview
  • 6.6.3 Cipla Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Cipla Ltd. Product Portfolio
  • 6.7.5 Cipla Ltd. Recent Developments/Updates
• 6.8 Glenmark Pharmaceuticals Inc.
  • 6.8.1 Glenmark Pharmaceuticals Inc. Corporation Information
  • 6.8.2 Glenmark Pharmaceuticals Inc. Description and Business Overview
  • 6.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Glenmark Pharmaceuticals Inc. Product Portfolio
  • 6.8.5 Glenmark Pharmaceuticals Inc. Recent Developments/Updates
• 6.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)
  • 6.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Corporation Information
  • 6.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Description and Business Overview
  • 6.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Product Portfolio
  • 6.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
• 6.10 Novartis AG
  • 6.10.1 Novartis AG Corporation Information
  • 6.10.2 Novartis AG Description and Business Overview
  • 6.10.3 Novartis AG Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Novartis AG Product Portfolio
  • 6.10.5 Novartis AG Recent Developments/Updates
• 6.11 Mylan N.V.
  • 6.11.1 Mylan N.V. Corporation Information
  • 6.11.2 Mylan N.V. Hormonal Contraception Description and Business Overview
  • 6.11.3 Mylan N.V. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Mylan N.V. Product Portfolio
  • 6.11.5 Mylan N.V. Recent Developments/Updates
• 6.12 Johnson & Johnson
  • 6.12.1 Johnson & Johnson Corporation Information
  • 6.12.2 Johnson & Johnson Hormonal Contraception Description and Business Overview
  • 6.12.3 Johnson & Johnson Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Johnson & Johnson Product Portfolio
  • 6.12.5 Johnson & Johnson Recent Developments/Updates
• 6.13 Ansell LTD
  • 6.13.1 Ansell LTD Corporation Information
  • 6.13.2 Ansell LTD Hormonal Contraception Description and Business Overview
  • 6.13.3 Ansell LTD Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Ansell LTD Product Portfolio
  • 6.13.5 Ansell LTD Recent Developments/Updates
• 6.14 Mayer Laboratories, Inc.
  • 6.14.1 Mayer Laboratories, Inc. Corporation Information
  • 6.14.2 Mayer Laboratories, Inc. Hormonal Contraception Description and Business Overview
  • 6.14.3 Mayer Laboratories, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Mayer Laboratories, Inc. Product Portfolio
  • 6.14.5 Mayer Laboratories, Inc. Recent Developments/Updates

7 Hormonal Contraception Manufacturing Cost Analysis

• 7.1 Hormonal Contraception Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Hormonal Contraception
• 7.4 Hormonal Contraception Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Hormonal Contraception Distributors List
• 8.3 Hormonal Contraception Customers

9 Hormonal Contraception Market Dynamics

• 9.1 Hormonal Contraception Industry Trends
• 9.2 Hormonal Contraception Growth Drivers
• 9.3 Hormonal Contraception Market Challenges
• 9.4 Hormonal Contraception Market Restraints

10 Global Market Forecast

• 10.1 Hormonal Contraception Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Hormonal Contraception by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Hormonal Contraception by Type (2022-2027)
• 10.2 Hormonal Contraception Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Hormonal Contraception by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Hormonal Contraception by Application (2022-2027)
• 10.3 Hormonal Contraception Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Hormonal Contraception by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Hormonal Contraception by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List